Publications by authors named "Carl Fletcher"

Claim this Profile
I
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.
Georg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, Andrea Antinori, Rafael Micán, Carl Fletcher

Lancet Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study.
Georg M N Behrens, Lambert Assoumou, Stephane De Wit, Rona MacDonald, Nathalie de Castro, Carl Fletcher

HIV Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of doravirine-based regimens in clinical practice in Europe.
Agathe Rami, Anton L Pozniak, Lambert Assoumou, Roya Movahedi, Karine Lacombe, Carl Fletcher

AIDS· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial.
Graeme Moyle, Lambert Assoumou, Nathalie de Castro, Frank A Post, Adrian Curran, Carl Fletcher

Lancet HIV· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of a combined mentalisation-based therapy and therapeutic community programme for adolescents with borderline personality disorder traits on service utilisation in Western Australia.
Jemima Robinson Lake, Natasha Bear, Carl Fletcher, Giulia Pace, Ivan Salmin

Personal Ment Health· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.
Nadir Arber, Pallav L Shah, Lambert Assoumou, Casper Rokx, Nathalie De Castro, Carl Fletcher

Infect Dis Now· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explosive detection using a novel dielectric barrier discharge ionisation source for mass spectrometry.
Carl Fletcher, Richard Sleeman, John Luke, Peter Luke, James W Bradley

J Mass Spectrom· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid identification of seized controlled substances and related compounds by tandem mass spectrometry without chromatography.
Carl M Fletcher, Richard Sleeman

Rapid Commun Mass Spectrom· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of low-dose ritonavir on human peripheral blood mononuclear cells using gene expression whole genome microarrays.
Saliha Yilmaz, Marta Boffito, Sophie Collot-Teixeira, Ferruccio De Lorenzo, Laura Waters, Carl Fletcher

Genomics· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.
Graeme Moyle, Marta Boffito, Carl Fletcher, Chris Higgs, Phillip E Hay

Antimicrob Agents Chemother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.
Marta Boffito, Alan Winston, Akil Jackson, Carl Fletcher, Anton Pozniak

AIDS· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV Type 1-infected individuals administered different atazanavir doses.
Marta Boffito, Desmond Maitland, Laura Dickinson, David Back, Andrew Hill, Carl Fletcher

AIDS Res Hum Retroviruses· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.
Alan Winston, David Back, Carl Fletcher, Lesley Robinson, Jennifer Unsworth

AIDS· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100 mg once daily versus twice daily.
Marta Boffito, Desmond Maitland, Laura Dickinson, David Back, Andrew Hill, Carl Fletcher

J Antimicrob Chemother· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-State pharmacokinetics of saquinavir hard-gel/ritonavir/fosamprenavir in HIV-1-infected patients.
Marta Boffito, Laura Dickinson, Andrew Hill, David Back, Graeme Moyle, Carl Fletcher

J Acquir Immune Defic Syndr· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of once-daily saquinavir/ritonavir in HIV-infected subjects: comparison with the standard twice-daily regimen.
Marta Boffito, Laura Dickinson, Andrew Hill, David Back, Graeme Moyle, Carl Fletcher

Antivir Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?
Alan Winston, Anton Pozniak, Nicola Smith, Carl Fletcher, Sundhiya Mandalia

AIDS· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis